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ABSTRACT 
Experiments were conducted in which the responses of nonesterified fatty
 
acids (NEFA) and glucose to insulin and epinephrine were used to qualitativel
 
assess the state of body fat and carbohydrate reserves during prolonged exer­
cise. Intravenous insulin (0.0. units/kg) administered to normal fasting
 
humans after 8 hr of aerobic treadmill work caused a precipitous drop in mean 
serum glucose and NEFA levels to 41 mg/100 ml and 0.994 meq/1, respectively. 
Subjects were able to continue walking despite signs and symptoms of severe 
hypoglycemia and glucose and NEFA returned to preinjection levels within 
3 hr. Intramuscular epinephrine (0.10 mg/kg) caused a significant rise in 
serum glucose, but NEFA values were relatively unaffected as compared to
 
resting controls. Indications are that at the time of injection, a) liver
 
glycogen stores were significantly lower in the working than in the resting
 
group, but were not depleted to the extent anticipated following a 2500 kcal
 
energy expenditure and 21 hr of fasting, and b) NEFA were being mobilized 
from adipose tissue at a maximum rate. Possible mechanisms regulating the 
availability of energy from fat depots are briefly discussed.
 
INDEX TERMS
 
energy metabolism in humans, lipid and carbohydrate reserves,.NEFA, glucose,
 
insulin, epinephrine, prolonged work 
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Intensive investigative work of the past decade has led to markedly
 
revised doncepts of the role of lipids in energy metabolism. It is now
 
recognized that the nonesterified fatty acids (NEFA), loosely bound to
 
albumin, a) are the transport form of energy from adipose tissue, b) can
 
be directly oxidized by a variety of tissues including myocardium (9) and
 
skeletal muscle (15), and c) are ex-remely sensitive to environmental,
 
hormonal, and drug influences. However,/the conditions under which this
 
energy is made available, the degree to which it may be used without the
 
development of harmful ketoacidosis, and its relationships to carbohydrate
 
utilization are not well understood.
 
The difficulties in investigating these problems often result from
 
the failure to establish true steady-state experimental conditions and 
from the inability to evaluate the s-ate of body energy reserves in the
 
intact animal. Consequently, a series of experiments were initiated in 
which postadsorptive dogs (18) and men (19) were required to perform aero­
bic work on a treadmill for periods up to 40 hr and 24 br, respectively,
 
or until the onset of fatigue. The human studies confirmed earlier
 
observations in dogs, a) that mean glucose values declined slowly during
 
the first 9 hr and then remained constant for the duration of the test,
 
b) that mean NEFA values increased fourfold during the same period and
 
remained constant thereafter, c) that only 3-5% of the total energy expen­
diture was provided by protein utilization, and d) that it was possible to 
prevent dehydration, electrolyte imbalance, and excess lactate formation 
under.these conditions by carefully controlling water and salt intake and
 
the rate of energy expenditure. Hence, a set of conditions could be repro­
duced in which steady-state values of glucose and EFA could be maintained
 
for prolonged periods. In the absence of food intake and significant
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protein breakdown, these constant levels are sustained by continuous influx
 
from body lipid and carbohydrate storage depots. The ability of insulin
 
and epinephrine to moderate glucose and NEFA release from these storage
 
depots, and consequently blood levels, is well known and their mechanisms
 
of action are well defined.
 
This paper reports the responses of serum lipids and glucose to these
 
drugs' and attempts to qualitatively evaluate the extent of depletion of
 
human glycogen and lipid reserves after approximately 8 hr of aerobic tread­
mill walking.and 21 hr of fasting.
 
MTHODS 
Following a 3-month obligatory physical conditioning program, 20 normal
 
male subjects between the ages of 22 and 40 years were required to partici­
pate in each of the following test situations over a 6-month period:
 
a) Walk on a treadmill at one-third maximum capacity for 24 hr or
 
until the onset of fatigue.
 
b) Remain at rest without sleeping (basal) for 24 hr under conditions
 
identical to (a).
 
c) Receive either insulin or adrenalin during the course of a 12-hr
 
treadmill walk.
 
d) Receive either insulin or adrenalin as in (c) while under basal
 
conditions.
 
Factors, such as room temperature, lighting, noise, and humidity, were
 
kept constant. Water was permitted ad libitum above a minimum rate of
 
300 cc over 1-1/2 hr. One gram of salt was given every 4 hr. Blood samples
 
were drawn at 1-1/2 hr intervals through an indwelling polyethylene catheter
 
inserted into an antecubital vein. Cardiovascular status was evaluated
 
continuously by cardiotachometer, elec-rocardiogram (oscilloscope and
 
standard readout), and blood pressure determination. 
All work was aerobic and was performed by walking on a treadmill 
adjusted to impose a workload equivalent to one-third maximum capacity 
as determined prior A modified Master's Twoto testing. Step Test uas
 
performed prior to working sessions. Treadmill grade and speed settings 
varied from 0-3 degrees inclination and from 2.6 to 2.9 mph. Subjects
 
walked for 1-hr and 20-min periods and 10 min were allowed for rest, 
foot care, blood and urine sampling, and blood pressure readings. 
Resting subjects remained in a semireclining position and could read, 
w.rite, or watch television, but were not permitted to sleep. 
Groups (a) and (b) constituted the "24-hr series" and groups (c) and 
(d) the "drug study." Since the same sibojects performed under identical 
conditions in both experiments, some of the baseline information obtained 
in the 24-hr series was applied to the-drug study. For example, determina­
tions; such as a respiratory quotient, hematocritu sodium, potassium, non­
protein nitrogen, urinary nitrogen, and creatinine and ketone bodies,
 
reported in the 24-hr series experiment (19), *ere not repeated in the
 
present drug study. However, serum glucose (13) (14), NEFA (3) (16),
 
Lactic acid (10), and ohosphorus (6) determinations were performed.
 
Approximately 8 hr after the start of the test, a preinjection blood 
sample was drawn through the indwelling catheter and the subjects were given 
either 0.05 units/kg of regular insulin, inttavenously (Zinc Insulin, U-40, 
E. R. Squibb and Sons, New York), or 0.10 mg/kg of epinephrine hydrochloride, 
intramuscularly (Adrenalin, 1:1000, Parke, Davis and Co., Detroit). Blood 
samples were then obtained 15-min, 30 min, 45 min, 1 hr, 1-1/4 hr, 1-1/2 hr 
and 3 br after injection. 
Fig. 1 
RESULTS 
1) Serum Glucose 
a) Twenty-four hour series - (Fig. 1 - dotted areas). During the 
first 9 hr glucose levels gradually declined from mean values of 
86.10 mg/lo0 ml (SD ±10.00) to 76.90 mg/lo0 ml (SD ±9.24) in the resting 
subjects and from 89.78 mg/1O0 ml (SD ±8.90) to 65.38 mg/lO0 ml (SD ±6.23 
in the working subjects. Thereafter, mean glucose concentrations leveled
 
off and were constant for the remainder of the work and rest periods
 
(Scheffe's Multiple Comparison Test).
 
b) Epinephrine administration - (0.10 mg/kg intramuscular). 
Effects of epinephrine administered during the ninth hour after start of 
the test are shown in Figs. 1A and lB. In the resting subjects within 
45 min there was a marked increase in serum glucose levels from 77.40 
(SD ±7.23) to 114.80 (SD tl.lO) with a slow return to preinjection 
levels after 2-3 hr. Working subjects showed a similar but less dramatic 
response. Levels rose from 63.90 mg/lo ml (SD ±6.58) to 87.00 mg/la0 ml 
(SD ±15.00) 45 min after injection. The level of response of the resting
 
subjects was significantly higher (p < 0.005) than that of the working 
subjects. The response of both groups 45-60 min after injection was sig­
nificantly higher (p < 0.001) than preinjection levels as well as the 3-hr 
postinjection levels. 
c) Insulin administration - (0.05 units/kg intravenous). -Effects 
of insulin on-mean serum glucose levels are shown in Figs. 1C and 1D. As
 
expected, within 30 min there was a precipitous drop from 76.90 mg/100 ml 
(sD ±8.82) to 38.90 mg/100 ml (sD ±6.33) in the resting subjects and from 
71.00 mg/100 ml (SD ±9.26) to 41.oo mg/lob ml (sD ±9.Ol) in the working 
subjects. At the end of 3 hr, glucose values had returned to 100% and 
92% of preinjection concentrations in rest and work subjects, respectively. 
The clinical manifestations of hypoglycemia appeared to be of equal 
severity in both groups; however, recovery was somewhat slower in the 
workins subjects as measured by the rate of return of glucose levels 
(Fig. 1D) and performance on psychomotor tests (Coler, C. R., W'. A. McLaurin,
 
and D. R. Young. Effect of Adrenalin or Insulin on the Performance of
 
Resting and Working Subjects. Presented at the Aerospace Medical Association
 
36th Annual Scientific Meeting, April 26-29, 1965, New York City, New York.)
 
2) Serum Nonesterified Fatty Acids
 
a) Twenty-four hour series - (Fig. 2 - dotted areas). During the
 
first 9 hr NEFA levels'rose continuously from mean values of 0.546 meq/1,
 
to 0.940 meq/1 in the resting subjects and from 0.650 meq/1 to 2.244 meq/1
 
in the working subjects. Thereafter, mean NEFA concentrations plateaued
 
and remained constant for the remainder of the work and rest periods
 
(Scheffe's Multiple Comparison Test).
 
b) Epinephrine administration - (0.10 mg/kg intramuscular).
 
Effects of epinephrine administered during the ninth hour after the start
 
of the test are shown in Figs. 2A and 2B. In the resting subjects NEFA
 
levels doubled to mean values of 2.43 meq/1 (SD ±0.577) 30 min after
 
injection with slow decline to preinjection levels at the end of 3 hr.
 
In the working subjects, however, mean values increased only from 2.50 meq/l
 
(sD ±0.622) to 2.87 meqj (SD ±0.612) 30 min after injection. Although 
statistically real (p < 0.05), this small change is of questionable 
biological slignificance.
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c) Insulin administration - (0.05 units/kg intravenous). Effects 
of insulin administered during the ninth hour after the start of the test 
are shown in Figs. 2C and 2D.- A sharp fall in NEFA levels was observed in 
the working subjects. Forty-five minutes after injection, levels dropped 
from a preinjection mean of 2.061 meq/l (SD ±0.721) to 0.994 me/i 
(SD ±0.172) and then returned to 2.069 meq/1 (SD ±0.350) at the end of 
3 hr. The changes that occurred in the resting subjects fell within 
the same range as those during an equivalent time interval in the 24-hr 
series in which no drug was given (Fig. 2C). 
3) Serum Lactate (Table 1)
 
a) Epinephrine administration - The lactate levels attained in both
 
rest and work subjects within the first hour after injection did not differ
 
statistically from each other nor did the average response differ during
 
the postinjection period. However, the postinjection response curves were
 
significantly different (p < 0.001), with lactate levels continuing to rise
 
slightly in the workers but showing no definite pattern in the resting
 
subjects. The observed rises within each group were significant (p < 0.05).
 
b) Insulin administration - Neither the average response nor the
 
shapes of the response curves during the postinjection period differed sig­
nificantly between the work and rest subjects. Both showed a small,.but
 
significant (p < 0.01), peak response at about 45 min with slow return to
 
preinjection levels at 3 hr.
 
4) Serum Inorganic Phosphate (Table 2)
 
a) Epinephrine administration - Preinjection phosphate levels were
 
identical in the work and rest subjects and did not change significantly
 
in either group throughout the postinjection period.
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b) Insulin administration - There was a significant (p < 0.05) fall 
in phosphate levels in both groups within 45 min after injection followed 
by a persistent rise. The pattern of response was the same. However, in 
the working subjects, the rise began somewnat earlier and by 3 hr phosphate
 
levels were significantly higher (p < 0.05) than at preinjection.
 
DISCUSSION
 
Carbohydrate Reserves. The glycemic responses observed in the resting
 
and working subjects can be ascribed to the known abilities of epinephrine
 
a) to stimulate liver glycogenolysis, b) to decrease the uptake of glucose
 
by tissues, and c) to elevate blood lactate levels (lactate - liver glycogen 
glucose). However, in working and resting subjects lactate levels were not 
significantly different during the peak glucose response following epine­
phrine (Table 1). Nor did phosphate levels differ significantly (Table 2),
 
thus substantiating the observation that inhibition of uptake is extremely
 
small at these glucose levels (2). Consequently, the greater rise in
 
glucose concentrations attained in the resting subjects as compared to
 
working subjects was probably due to a larger amount of liver glycogen
 
available in the former group at the time of injection.
 
Although carbohydrate stores were apparently being utilized to a
 
greater extent in the- working subjects, mean blood glucose levels remained 
constant in both groups after the first 8 hr of testing and were only 
7.2 mg/100 ml higher in the resting subjects. To maintain these conditions
 
during work, extensive gluconeogenesis must have been taking place. In
 
the absence of significant protein breakdown (20) and lactic acid formation,
 
the major source of glucose is presumed to be fat. It can be estimated from
 
the data obtained in our preliminary experiments that approximately 0.30 kg
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of body fat was lost up to the time of injection, of which about one-tenth 
by weight, or 0.03 kg was glycerol. This amount of glycerol could con­
ceivably sustain glycogen stores in view of its extremely rapid conversion
 
to carbohydrate. In the fasting rat, e.g., 75-90% of endogenous glucose
 
is derived from glycerol (12). However, the possibility that the NEFA
 
component of fat also serves as an important precurser of carbohydrate
 
must be considered, since a) the Krebs cycle can act as a metabolic path­
way for the synthesis of glucose from NEFA in the presence of a nonacetate
 
influx (17), b) NEFA are a major source of carbohydrate in plants and
 
probably insects, and c) there is no direct evidence that such a con­
version does not occur readily in humans. Additional studies are needed
 
to clarify the role of NEFA as a quantitatively significant source of
 
carbohydraze during prolonged fasting and work.
 
Following the administration of insulin, glucose concentrations fell
 
to approximately the same levels in resting and working subjects (Figs. 1C,
 
1D) despite the differences in liver glycogen content. The failure of
 
blood glucose levels to fall bel6w 38.9 mg% (SD ±6.3) can be attributed,
 
at least in part, to inhibition of glucose uptake by adrenal medullary
 
hormones stimulated by severe hypoglycemia. Serum phosphate concentrations
 
also fell initially to the same levels in work and rest subjects following
 
intravenous insulin (Table 2), indicating comparable rates of carbohydrate
 
utilization. However, within 1 hr after injection, phosphate levels in
 
both groups began to rise. By 3 hr they exceeded preinjection values,
 
suggesting, again,.the presence of a mechanism acting at hypoglycemic
 
levels to restore blood glucose by inhibition or depression of peripheral
 
uptake.
 
Livid Reserves. Muscle and liver biopsy techniques have contributed
 
a great deal to the understanding of carbohydrate metabolism, despite their
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many obvious limitations. Investigators of fat metabolism.are deprived
 
of even these simple tools since sampling and analysis of adipose tissue
 
provides no information regarding the amount of energy utilized or that
 
still available from fat. The fluctuations of blood NEFA concentrations
 
and turnover rates under various experimental conditions represent the
 
end result of many complex factors regulating fat utilization and have 
been extensively studied in recent years. However, these studies have 
led to many conflicting reports as, for example, those regarding the
 
response of IEFA to exercise in the fasting state. Initially, it was 
shown that there was an increased turnover rate and low concentration of
 
NEFA with short periods (approximately 15 min) of vigorous exercise
 
followed by a sharp rise when activity was stopped (7). Subsequent obser­
vations revealed that during less severe exercise of longer duration, a
 
brief fall in concentration occurred, followed by a gradual rise (1), and
 
was accompanied by an increased turnover rate (8). Recently, Mager et al
 
(11) extended periods of aerobic ex6rcise to 7 hr and showed a continual
 
increase in NEFA levels.
 
The contribution of our preliminary tests (19) to this area of intere 
is the demonstration that after approximately 8-9 hr of aerobic work in
 
the fasting normal human, NEFA remained constant for periods up to 15 hr. 
This must mean that the rate of efflux of NEFA from the blood equaled the
 
rate of influx during this interval. In view of the previously mentioned 
evidence that NEFA are a major energy source for working muscle and that
 
their turnover rate is increased during exercise, it is presumed that the 
rate of flux under these conditions must be extremely rapid. Quantitative 
studies utilizing radioactive isotope techniques are currently in progress 
in our laboratory. The failure to obtain steady-state conditions probably 
accounts for many of the discrepancies of earlier observations. 
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The increase in NEFA levels following the administration of epinephrine 
is well known and Jis presumed to result from increased hydrolysis of tri­
glycerides in adipose tissue. Such a response occurred in our resting sub­
jects, resulting in almost a twofold increase in NEFA concentration (Fig. 2A).
 
However, the change that occurred in the working subjects, while statisti­
cally significant (p < O.001), was extremely small (Fig. 2B) and probably
 
not of biological importance.- Even if it is assumed that the total cost
 
of energy requirements was met by fat tissue) still an insignificantly small
 
amount of fat as compared to total body fat would have been expended and
 
could not account for the failure of epinephrine to raise NEFA levels in
 
the working subjects. Apparently, NEFA were being mobilized maximally at
 
the time of injection.
 
One or more of the following factors could have prevented the anticipated
 
NEFA increase: a) an inadequate supply of lipolytic enzyme to meet the new
 
requirements, b) saturation of available binding sites on plasma albumin
 
c) saturation of NEFA "tissue acceptor" sites which may be located in cell
 
membranes and organelles (5), or d) saturation of cellular metabolic pathways
 
which are required to activate NEFA for oxidation or esterification.
 
The most likely possibility is that plasma albumin sites were saturated
 
since it has been demonstrated, in vitro, that NEFA will not be released
 
from adipose tissue even in the presence of potent lipolytic agents unless
 
the incubation medium contains albumin (4). However, if it can be shown
 
that insufficient lipolytic enzyme is the rate limiting step, then supplying
 
such enzymes could, conceivably, make available large amounts of storage fat 
for energy metabolism.
 
Insulin inhibits the release of fatty acids from adipose tissue by 
interfering with the activation of lipase. The fall in NEFA concentrations 
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that occurred in the working subjects (Fig. 2D) was therefore not unexpected.
 
However, the failure of this mechanism to act effectively in The resting
 
subjects cannot be adequately explained in light of the present information.
 
It is of further interest that mean NEFA concentrations fell to approxi­
mately the same levels in the insulin-treated working and resting groups as
 
well as in the nontreated resting controls (Figs. 2C, 2D). In no case did
 
NEFA levels fall below 0.6o4 meq/1 (SD ±0.155). Similarly, working and
 
resting subjects who received epinephrine attained the same mean NEFA levels
 
observed in the working controls who received no drug, the maximum levels
 
being 2.87 meq!1 (SD ±0.612) (Figs. 2A, 2B). Apparently, the upper and
 
lower limits beyond wich NEFA blood levels were not influenced by prolonged
 
fasting, work, rest, or pharmacological doses of insulin and epinephrine,
 
were approximately 2.9 meq/1 and 0.6 meq!1, respectively. Similar effects
 
were noted in the glucose experiments, the lower limits being established
 
at about 40 mg/100 ml (Figs. 1C, 1D). Clarification of the mechanisms
 
tending to maintain NEFA and glucose levels at these relatively rigid boundaries
 
would contribute greatly to an understanding of the factors controlling the
 
availability of energy from lipid and carbohydrate storage depots during
 
nrolone work and fasting. 
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FOOTNOTE 
'The term "drug"' is used in its broader sense, recognizing that insulin 
and epinephrine are naturally occurring hormones. 
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TABLE LEGLTfS
 
Table I.- Response of serum lactate to adrenalin or insulin 
*Adrenalin (I.M.) or insulin (I.V-) vas administered to postadsorptive 
working and resting subjects approximately 8 hr after the start of the test.
 
Values are mean mg/lO0 ml ±SD.
 
Table 2.- Response of serum inorganic phosphate to adrenalin or insulin*
 
*Adrenalin (I.M.) or insulin (I.V.) was administered to postadsorptive
 
working and resting subjects approximately 8 hr after the start of the test.
 
Values are mean mg/lO0 ml ±SD.
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FIGURE LGZMDS
 
Fig. 1.- Serum glucose versus duration of test, hr.
 
Hatched areas represent the mean and standard deviation for 12 subjects
 
who received either insulin or adrenalin 8 hr after the start of the test.
 
Dotted areas represent the mean values expressed as standard deviation for
 
16 control subjects ho received no drug. (A) mean response of serum
 
glucose to adrenalin in postadsorptive resting subjects, (B)mean response
 
of serun glucose to adrenalin in postadsorptive working subjects, (C) mean
 
response of serum glucose to insulin in postadsorptive resting subjects,
 
(D) mean response of serum glucose to insulin in postadsorptive working
 
subjects.
 
Fig. 2.- Serum nonesterified fatty acids (NEFA) versus duration of test) hr.
 
Hatched areas represent the mean and standard deviation for 12 subjects
 
who received either insulin or adrenalin 8 hr after the start of the test.
 
Dotted areas represent the mean values expressed as standard deviation for
 
16 control subjects ho received no drug. (A) mean response of NEFA to
 
adrenalin in postadsorptive resting subjects, (B) mean response of "NEFAto
 
adrenalin in postadsorptive working subjects, (C) mean response of NEFA to
 
insulin in postadsorptive resting subjects, (D) mean response of NEFA to
 
insulin in postadsorptive working subjects.
 
ADRENALIN, .10 mg/kg I.M. 
Ohr Ihr3O 3hr 4hr3O 6hr 8hr15 8hr30 8hr45 9hr 9hrl5 9hr3O 9hr45 Ilhr15 
REST 10.1+ .92 11.3±-1.73 10.4±-1.31 ± 10.21.11 10.1± 1.03 10.8±1.70 12.7±2.32 13.2±3.27 13.2±2.42 13.3±2.31 12.2±-1.70 ± 11.91.01 ± 11.41.78 
LJ 
I­
o WORK 10.4 10.0 10.2 10.6 10.4 11.9 12A 13.1 13.7 14.1 13.8 144 14.8 
-1.01 ±1.04 ±1.59 ± .52 ± .98 ±-1.09 ± 1.68 ±2.06 ±2.26 ± 1.91 ±2.28 ±2.03 ±-2.55 
w INSULIN, .05 units/kg I.V. 
REST 11.2+ 1.25 ± 10.91.40 11.22.20 10.6±1.98 [0.4±1.67 11.5±2.09 12.1±2.52 13.0±2.35 13.2± 2.17 12.4±1.91 .12.0±_1.90 11.7±-2.22 ± 11.51.70 
10.8 10.1 10.2 10.1 10.6 11.2 12.0 14.1 14.3 14.0 13.4 13.2 12.9 
W-2.17 1.42 ± 1.40 ±+1.03 ±1.75 ± 1.51 ±-1.72 ±2.89 ± 3.62 ±3.07 ±2.74 ±2.90 ± 2.88 
INJECT-cz 
Table 1 
NAIONAt AERONAUTICSAND SPACE ADMINISTRATION 
AMES RESEARCH (ENER 4,OFFITIPEN.OCAtLFORNIA 
ADRENALIN, .10 mg/kg I.M. 
Ohr Ihr3O 3hr 4hr3O 6hr 8hrl5 8hr30 8hr45 9hr 9hrI5 9hr3O 9hr45 Ilhr15 
w 
REST 
3.6 
+-.80 
3.3 
± .62 
3.4 
± .50 
3.6 
±.46 
3.6 
± .54 
3.6 
±.50 
3.3 
±.54 
3.3 
±A4 
3.4 
.48 
3.4 
.43 
3.5 
.44 
3.4 
± .42 
3.5 
± .56 
D-
UO 
0 
WORK+ 
3.2 
.59 
3.1 
.69 
3.6 
±41 
3.6 
±.55 
3.8 
.41 
3.6 
±.70 
3.4 
.75 
3.7 
.67 
3.5 
.70 
3.8 
.93 
3.9 
±.87 
3.8 
± .77 ± 
3.9 
.85 
:D 
U) 
REST 3.6 
± .42 
3.2 
±.40 
3.4 
± .34 
INSULIN, .05 units/kg 
3.6 3.7 3.7 3.3 2.9 
.26 ±.30 ±.23 ±.28 ±.35 
I.V. 
2.6 
±.40 
2.9 
±.43 
3.2 
±.33 
3.4 
.48 ± 
3.9 
.48 
WORK 3.3 
± .35 
3.6 
±.46 
3.7 
±.36 
3.8 
±.33 
3.8 
±,20 
3.8 
±.20 
3.4 
±.42 
2.9 
± .41 
3.0 
±.45 
3.5 
±.28 
3.9 
±.38 
4.0 
.40 ± 
4.3 
.43 
INJECT-c> 
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